What could be causing jaw clenching in an adult or adolescent patient with a history of depression or anxiety since starting sertraline (selective serotonin reuptake inhibitor, SSRI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Jaw Clenching Since Starting Sertraline

Jaw clenching (bruxism) is a recognized adverse effect of sertraline and other SSRIs, caused by serotonergic effects on motor control pathways, and typically requires dose adjustment, medication switching, or symptomatic management.

Mechanism and Incidence

  • SSRIs including sertraline commonly cause motor side effects through serotonergic modulation of dopaminergic pathways in the basal ganglia, leading to extrapyramidal symptoms like bruxism, jaw clenching, and teeth grinding 1.

  • While the American Academy of Child and Adolescent Psychiatry guidelines note that typical SSRI adverse effects include nausea, dry mouth, drowsiness, and reduced libido, motor symptoms like jaw clenching represent less commonly discussed but clinically significant side effects 1.

  • These symptoms can occur at any dose but may worsen with dose escalation, as higher doses of SSRIs are associated with increased frequency of adverse effects 1.

Management Algorithm

First-Line Approach: Dose Reduction

  • Reduce the sertraline dose to the lowest effective level (typically 25-50 mg daily), as lower doses effective for anxiety and depression may reduce the frequency and severity of adverse events 1.

  • Monitor for 1-2 weeks after dose reduction to assess whether jaw clenching improves while maintaining therapeutic benefit for the underlying anxiety or depression 1.

Second-Line Approach: Medication Switch

  • Switch to an alternative SSRI with lower motor side effect profile, such as citalopram or escitalopram, which have the least effect on CYP450 isoenzymes and may have different adverse effect profiles 1.

  • When switching, taper sertraline gradually over 1-2 weeks to avoid discontinuation syndrome (characterized by dizziness, fatigue, myalgias, headaches, nausea, insomnia, anxiety, and agitation), as sertraline is a shorter-acting SSRI with higher discontinuation rates 1, 2.

Symptomatic Management Options

  • Consider adding a dental night guard to prevent tooth damage from nocturnal bruxism while addressing the underlying medication cause 1.

  • Avoid adding benzodiazepines for muscle relaxation, as this creates polypharmacy risks and potential for another withdrawal syndrome 2.

Critical Differential Considerations

Rule Out Serotonin Syndrome

  • Assess for additional serotonin syndrome features including mental status changes, neuromuscular hyperactivity (hyperreflexia, clonus, muscle rigidity, tremor), and autonomic instability (fever, sweating, tachycardia) 3.

  • Jaw clenching alone is typically an isolated motor side effect, but if accompanied by these other features, immediately discontinue sertraline and provide supportive care 3.

  • Review all concomitant medications for serotonergic agents, including tramadol, other antidepressants, stimulants, dextromethorphan, and St. John's Wort, which increase serotonin syndrome risk 3.

Evaluate for Drug Interactions

  • Sertraline interacts with drugs metabolized by CYP2D6, which may increase adverse effects if the patient is taking multiple medications through this pathway 1.

  • Higher medication dosages and concomitant use of CYP2D6 inhibitors increase risk of adverse effects including motor symptoms 3.

Common Pitfalls to Avoid

  • Do not simply increase the dose assuming the jaw clenching will resolve with time—motor side effects typically persist or worsen with higher doses 1.

  • Do not dismiss this as anxiety-related muscle tension—the temporal relationship with sertraline initiation and the specific pattern of jaw clenching point to medication effects rather than the underlying psychiatric condition 2.

  • Do not abruptly discontinue sertraline without tapering, as this will cause discontinuation syndrome with symptoms that may be confused with relapse of the underlying anxiety disorder 1, 2.

  • Ensure parental oversight of medication regimens in adolescent patients, as adherence and adverse effect monitoring are paramount 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Citalopram Discontinuation and Sleepwalking

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Risk of Serotonin Syndrome with Sertraline and Trazodone Combination

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.